{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":361,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":361,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"60e1f68fa11d","filters":{"venue":"Lung Cancer"}},"results":[{"id":"W2116720928","doi":"10.1016/j.lungcan.2013.07.025","title":"Genetic alterations defining NSCLC subtypes and their therapeutic implications","year":2013,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; Canadian Institutes of Health Research; Canary Foundation; U.S. Department of Defense","keywords":"Lung cancer; Medicine; Disease; Cancer; Adenocarcinoma; Oncology; Bioinformatics; Cancer research; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.03775695014878454,"gpt":0.3931468609866038,"spread":0.3553899108378193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000269263,0.0003217901,0.0007484123,0.0001238021,0.0001920463,0.00006975568,0.00007815085,0.0001450607,0.0001966074],"category_scores_gemma":[0.00000714912,0.0002077387,0.0001881439,0.0002136631,0.00005513602,0.00005917643,0.00002922625,0.0001911508,0.00004720777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002912852,"about_ca_system_score_gemma":0.0007026072,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002258663,"about_ca_topic_score_gemma":0.00007755151,"domain_scores_codex":[0.9989567,0.0000328182,0.0003226599,0.0003814717,0.00007555393,0.0002307545],"domain_scores_gemma":[0.9991341,0.00009010689,0.0001594905,0.0003980347,0.00008877867,0.0001294429],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001181537,0.00003535606,0.0002962111,0.002134889,0.001006726,0.000001214911,0.0002439813,0.000002356672,0.000002412773,0.001040669,0.001103297,0.9941317],"study_design_scores_gemma":[0.0003988435,0.00004474293,0.001127463,0.004434269,0.005339234,0.00008411378,0.00002417619,0.00002037557,0.00000119832,0.0001849334,0.9880963,0.0002443616],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003780876,0.9948393,0.0004592128,0.0005414383,0.0001988576,0.001643605,0.0002087253,0.00006576196,0.002005308],"genre_scores_gemma":[0.0003383415,0.9936609,0.0006884746,0.0003466969,0.0002324511,0.003186298,0.0002228842,0.00007157964,0.001252336],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9938874,"threshold_uncertainty_score":0.8471339,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059812828","doi":"10.1016/j.lungcan.2013.07.026","title":"Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature","year":2013,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Radiosurgery; SABR volatility model; Lung cancer; Radiation therapy; Oncology; Internal medicine; Stage (stratigraphy); Randomized controlled trial; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.02084903947168593,"gpt":0.3515714696972276,"spread":0.3307224302255417,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003661742,0.0008035414,0.004841518,0.0001928658,0.00004982416,0.00006083496,0.0005228998,0.0002351162,0.0005773502],"category_scores_gemma":[0.00003093591,0.0004089808,0.0009569654,0.001152416,0.00004888738,0.0001065096,0.0001037265,0.0006601292,0.00001448344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00190524,"about_ca_system_score_gemma":0.001244476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002169952,"about_ca_topic_score_gemma":0.0006062789,"domain_scores_codex":[0.9962824,0.0004230935,0.001514121,0.0007246802,0.0005497044,0.0005059981],"domain_scores_gemma":[0.9964707,0.0001395015,0.001354355,0.001554859,0.0002820699,0.0001985441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000003838999,0.0001794687,0.0008639556,0.978532,0.001149211,0.00003471744,0.00109679,0.000001721808,2.114229e-7,0.000003474796,0.00524192,0.01289271],"study_design_scores_gemma":[0.000643397,0.00006819062,0.0001000066,0.9601562,0.01778431,0.00001747217,0.00002053774,0.00004199471,0.000009422687,0.000004500454,0.02081783,0.0003361299],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001904475,0.9843764,0.000001731263,0.000317439,0.0005250769,0.01355893,0.000721749,0.00002168493,0.0002864863],"genre_scores_gemma":[0.00008898193,0.9818812,0.00005460877,0.001253217,0.0001480043,0.01312142,0.00008307115,0.0001395398,0.00322997],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01837577,"threshold_uncertainty_score":0.9998362,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2655216406","doi":"10.1016/j.lungcan.2017.06.014","title":"Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":246,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Institut universitaire de cardiologie et de pneumologie de Québec; Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Lung cancer; T790M; Internal medicine; Missense mutation; Oncology; Epidermal growth factor receptor; Sanger sequencing; Mutation; Cancer; Gefitinib; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.004125159358973921,"gpt":0.2923107701616074,"spread":0.2881856108026335,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004360115,0.0002058347,0.0003413852,0.0001077177,0.0001435348,0.00003216537,0.00007847502,0.00008225939,0.00002876638],"category_scores_gemma":[0.00003866337,0.00015797,0.00003457259,0.0001060593,0.0001084181,0.0001863664,0.00002659791,0.0001377652,9.261061e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004275508,"about_ca_system_score_gemma":0.0004224659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002160891,"about_ca_topic_score_gemma":0.0005446101,"domain_scores_codex":[0.9989167,0.00002442425,0.0002179766,0.0003396672,0.0002396988,0.0002614736],"domain_scores_gemma":[0.9990259,0.00007221336,0.0002808459,0.0002773941,0.0002249838,0.0001186322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000580798,0.0002825615,0.991522,0.001281591,0.0003856545,0.00003511113,0.002416429,0.000212641,0.0002473874,0.000004029958,0.000277132,0.002754622],"study_design_scores_gemma":[0.01095929,0.0006027328,0.9788014,0.002123222,0.001536087,0.000001069226,0.00005454873,0.002428324,0.003302243,0.000005747217,0.0000252837,0.000160111],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931352,0.001942202,0.0001837354,0.0001488133,0.0002496905,0.002707151,0.0001407295,0.00002266436,0.001469803],"genre_scores_gemma":[0.9981935,0.0001838788,0.0001554625,0.00008295144,0.00006481873,0.0008190715,0.0001044669,0.00003835826,0.0003575166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0127207,"threshold_uncertainty_score":0.644183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142559775","doi":"10.1016/j.lungcan.2011.10.009","title":"Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Hazard ratio; Lung cancer; Proportional hazards model; Oncology; Prospective cohort study; Performance status; Cancer; Physical therapy; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.02164013870391925,"gpt":0.2471534945676076,"spread":0.2255133558636884,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008143112,0.0002025835,0.0003880455,0.0001106057,0.00003432863,0.000007053461,0.00006433937,0.000058933,0.0004944726],"category_scores_gemma":[0.000007150406,0.0001655165,0.00005003153,0.0002657485,0.000107749,0.00009174041,0.00002511044,0.000196035,8.083681e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001992943,"about_ca_system_score_gemma":0.0002914603,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01259127,"about_ca_topic_score_gemma":0.01078971,"domain_scores_codex":[0.9987857,0.00002553601,0.000259908,0.000349488,0.0003029859,0.0002763192],"domain_scores_gemma":[0.9992504,0.00003020276,0.0001409189,0.0002100772,0.0002313103,0.0001371219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000878801,0.0003433225,0.9931175,0.001102166,0.0000549991,0.00001012707,0.00257879,0.00002347623,0.0002604572,0.000004272859,0.0001405728,0.001485523],"study_design_scores_gemma":[0.00252759,0.0002206649,0.992489,0.0007424852,0.0009644444,8.907566e-7,0.0001869722,0.0001476103,0.002478244,0.000003604961,0.00003702491,0.0002014858],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947878,0.002598469,0.0001759513,0.00001768038,0.000362646,0.001488061,0.0001356925,0.00001836857,0.0004152907],"genre_scores_gemma":[0.9977497,0.0001616921,0.0002685579,0.00008231333,0.00004365717,0.00129581,0.00001915727,0.00003390308,0.0003451384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00296193,"threshold_uncertainty_score":0.993984,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007240877","doi":"10.1016/j.lungcan.2013.05.007","title":"Clinical evaluation of microRNA expression profiling in non small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Lung Cancer","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":198,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"National and Kapodistrian University of Athens","keywords":"microRNA; Lung cancer; Pathogenesis; Gene expression profiling; Medicine; Cancer; Fold change; Gene expression; Cancer research; Pathological; Molecular biology; Pathology; Gene; Biology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01909446825335738,"gpt":0.3469983412357077,"spread":0.3279038729823503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004112248,0.0001199597,0.0001518864,0.00004130023,0.00002325082,0.0000105948,0.0001263083,0.0001822695,0.0002549346],"category_scores_gemma":[0.00003898003,0.0001142035,0.00007900025,0.00008039669,0.00003280281,0.000007703627,0.00006952701,0.00008960492,0.000002699059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001038791,"about_ca_system_score_gemma":0.0002916918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003666909,"about_ca_topic_score_gemma":0.0001486648,"domain_scores_codex":[0.9987944,0.000136473,0.0003717607,0.0003355099,0.0001784747,0.0001833218],"domain_scores_gemma":[0.9991791,0.0000109688,0.0002069773,0.0002705848,0.0002736162,0.00005880707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003342876,0.00004852623,0.1858865,0.0001289463,0.00001749187,1.340669e-7,0.00003833154,0.001648041,0.8067069,4.458988e-7,0.001813182,0.003678047],"study_design_scores_gemma":[0.00113161,0.00002064158,0.1370894,0.0002057976,0.00008196651,1.931347e-7,0.00002067618,0.02801829,0.8330902,0.000009909825,0.0001868639,0.0001444485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888177,0.009232618,0.0003124527,0.00004843809,0.0003022193,0.0009266653,0.00001675853,0.000005169446,0.0003380014],"genre_scores_gemma":[0.9977236,0.0004113424,0.0008138599,0.00006692514,0.0002788875,0.0004291644,0.0000672102,0.00002225041,0.0001867075],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04879707,"threshold_uncertainty_score":0.4657085,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3043250176","doi":"10.1016/j.lungcan.2020.07.014","title":"Mechanisms of osimertinib resistance and emerging treatment options","year":2020,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Osimertinib; Medicine; Acquired resistance; Cancer research; Epidermal growth factor receptor; Internal medicine; Receptor; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.03198790611506145,"gpt":0.4082846209134547,"spread":0.3762967147983932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002813372,0.0003037702,0.001279278,0.00009738249,0.00007338759,0.00001093565,0.00005211501,0.0001128854,0.0001981218],"category_scores_gemma":[0.0000108101,0.0002170564,0.0002806424,0.0002566939,0.00003879811,0.00003429082,0.00002460291,0.0001075668,0.000005265569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005707896,"about_ca_system_score_gemma":0.0007103464,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001162212,"about_ca_topic_score_gemma":0.00006401341,"domain_scores_codex":[0.9988546,0.00003358628,0.0004019688,0.000376633,0.0001552305,0.0001780118],"domain_scores_gemma":[0.9992399,0.00004714012,0.000258605,0.0002571993,0.00005304545,0.0001441301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002953313,0.0001041521,0.00001511911,0.01720185,0.003039409,0.00004876733,0.0004215337,0.000001298511,0.000008280057,0.00339503,0.001567927,0.9741671],"study_design_scores_gemma":[0.0006934862,0.0001160934,0.00001170783,0.01154969,0.01246209,0.00001159638,0.00002816939,0.00001278383,0.00001446209,0.00006557743,0.9748719,0.0001623891],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001799607,0.9953352,0.0002245036,0.0005078306,0.0002176418,0.001254893,0.0003446803,0.00004343294,0.002069997],"genre_scores_gemma":[0.00004399309,0.9916248,0.001415305,0.00006427299,0.0001179389,0.0008255472,0.0001300585,0.00005592154,0.005722219],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9740047,"threshold_uncertainty_score":0.8851305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073260977","doi":"10.1016/j.lungcan.2015.11.018","title":"Overexpression of KIF23 predicts clinical outcome in primary lung cancer patients","year":2015,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Lung cancer; Adenocarcinoma; Oncology; Medicine; Lung; Oncogene; Internal medicine; Cancer; Pathology; Cell cycle","retraction":null,"screen_n_in":null,"score":{"opus":0.01760095957507451,"gpt":0.3424362914841398,"spread":0.3248353319090653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001709715,0.0001301639,0.0002332088,0.00003223946,0.00001500245,0.000005811815,0.0001717029,0.0002144832,0.00002382964],"category_scores_gemma":[0.000060967,0.0001161186,0.00008298138,0.00006737073,0.00004681095,0.000006493948,0.0001645002,0.0001269646,8.582121e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001040507,"about_ca_system_score_gemma":0.0002477682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003110676,"about_ca_topic_score_gemma":0.0001780828,"domain_scores_codex":[0.9988293,0.00006008834,0.0004329698,0.0003013776,0.0001654496,0.0002108372],"domain_scores_gemma":[0.9993423,0.000009731704,0.0001632238,0.0002603476,0.0001181507,0.0001062788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000171339,0.0001417557,0.9489345,0.0001021292,0.00004217291,7.255844e-7,0.0000497547,0.0001769723,0.03308869,0.000003508386,0.01612094,0.001167525],"study_design_scores_gemma":[0.005464393,0.0002830841,0.9422513,0.0004859459,0.00009350308,8.125274e-7,0.00002037935,0.001738787,0.03101095,0.00001313344,0.01820145,0.0004363097],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948237,0.003072592,0.00007730455,0.00005029794,0.0006611052,0.0002795172,0.0001214279,0.000006686377,0.000907362],"genre_scores_gemma":[0.9970934,0.0009917435,0.0001412494,0.0005374541,0.0002818058,0.0000675018,0.0001363424,0.00002357963,0.0007269526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006683243,"threshold_uncertainty_score":0.473518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000856265","doi":"10.1016/s0169-5002(99)00093-8","title":"Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis","year":2000,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique; McGill University","funders":"Health Canada","keywords":"Medicine; Relative risk; Lung cancer; Meta-analysis; Tobacco smoke; Confidence interval; Confounding; Cohort study; Cohort; Cancer; Demography; Internal medicine; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.05685855619990769,"gpt":0.3766243320346775,"spread":0.3197657758347698,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003425659,0.0003482026,0.0028738,0.0001979124,0.00007966573,0.00002132101,0.0001512729,0.0002071472,0.004645267],"category_scores_gemma":[0.00001168888,0.0001911358,0.001817173,0.0004822134,0.00009758427,0.00003410597,0.00004628514,0.000352484,0.000001019807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000327513,"about_ca_system_score_gemma":0.0001353451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0034136,"about_ca_topic_score_gemma":0.0002392157,"domain_scores_codex":[0.9981385,0.0002103535,0.0005502019,0.0004374235,0.0004637594,0.0001997373],"domain_scores_gemma":[0.9987594,0.0001164317,0.0004056476,0.0005989409,0.00001886019,0.000100662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0001029781,0.00005603426,0.1135932,0.00258753,0.179502,0.000006891733,0.0006674716,0.0000778078,3.18132e-7,0.000007576367,0.001060508,0.7023376],"study_design_scores_gemma":[0.0004664414,0.00002447575,0.008554576,0.0004884411,0.7759982,0.000004152729,0.00001813072,0.000009402916,0.000001994384,7.181678e-7,0.2142569,0.0001765078],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006804901,0.9906744,0.000007180018,0.0001177625,0.0001299727,0.001267233,0.0008161423,0.00001455964,0.0001678576],"genre_scores_gemma":[0.01494345,0.9818737,0.00001119175,0.0001542104,0.0001796868,0.001262425,0.0001020851,0.00003982188,0.001433424],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7021611,"threshold_uncertainty_score":0.9962646,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949244813","doi":"10.1016/j.lungcan.2019.06.012","title":"Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study","year":2019,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Merck Sharp and Dohme; Merck","keywords":"Medicine; Lung cancer; Oncology; Expression (computer science); Cancer; Ligand (biochemistry); Pathology; Cancer research; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.01716188543011241,"gpt":0.3428035252477233,"spread":0.325641639817611,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003657109,0.0003350261,0.0005966107,0.00009495734,0.00006360479,0.00003120036,0.0003719249,0.00006492175,0.0004489173],"category_scores_gemma":[0.00001878194,0.000202032,0.000137484,0.0006040578,0.00008183804,0.0001493855,0.0001112537,0.0002481384,0.00000219169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000671845,"about_ca_system_score_gemma":0.0005442851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005848383,"about_ca_topic_score_gemma":0.007023771,"domain_scores_codex":[0.997624,0.0001369793,0.0006468132,0.0005777109,0.0005067259,0.0005077289],"domain_scores_gemma":[0.9985328,0.0001277992,0.0003523718,0.0007165302,0.0001595985,0.0001109326],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01306697,0.00103962,0.9208338,0.003355891,0.0003437732,0.0000346671,0.002765064,0.0003913583,0.04887681,0.000001410387,0.0004479868,0.008842669],"study_design_scores_gemma":[0.04554152,0.001851959,0.8164268,0.01272973,0.001766182,0.000007790393,0.003331767,0.00887241,0.1052665,0.000004691875,0.003321801,0.0008788646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815792,0.01021762,0.00008634468,0.0002379158,0.000546466,0.00671574,0.00006967162,0.00004281992,0.0005042052],"genre_scores_gemma":[0.9879411,0.004832807,0.0007228102,0.0003089428,0.00007165456,0.001619568,0.000005870007,0.00004441004,0.004452833],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.104407,"threshold_uncertainty_score":0.8841044,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052354574","doi":"10.1016/j.lungcan.2013.07.023","title":"Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors","year":2013,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cancer Care Ontario","funders":"University of Chicago","keywords":"Medicine; Radiation therapy; Lung; Primary tumor; Oncology; Lung cancer; Internal medicine; Carcinoma; Metastasis; Radiology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01012252538144662,"gpt":0.2650764802135764,"spread":0.2549539548321297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002447422,0.0003499434,0.0007104528,0.0001150947,0.00006534538,0.00002602284,0.00005645588,0.00007987233,0.0003762],"category_scores_gemma":[0.00001335672,0.0002265632,0.0001769558,0.0001278269,0.00009703326,0.00006556838,0.00003261903,0.00007431553,0.00001002142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009041491,"about_ca_system_score_gemma":0.000268929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005191828,"about_ca_topic_score_gemma":0.0001146053,"domain_scores_codex":[0.9984806,0.00003178795,0.0003975656,0.000423444,0.000263437,0.0004031637],"domain_scores_gemma":[0.9989141,0.0001859975,0.0001608023,0.0003378234,0.00009117189,0.0003100633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003491531,0.0009793929,0.9844881,0.0006360539,0.0005283181,0.00003926841,0.002391413,0.00001353074,0.0001580063,0.000008343282,0.0009607754,0.009761893],"study_design_scores_gemma":[0.004298994,0.00171414,0.9828424,0.0003240902,0.001552199,0.000008462068,0.0002543582,0.0008654723,0.007607437,0.000005962042,0.0002948812,0.0002316156],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847612,0.01118318,0.00002783475,0.0006228358,0.0002770144,0.002500117,0.00005965132,0.00003399261,0.0005341426],"genre_scores_gemma":[0.9967982,0.0009379263,0.0004560366,0.0001675804,0.00005166149,0.001196512,0.00003328346,0.00004474062,0.0003140722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01203695,"threshold_uncertainty_score":0.9238977,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2609723037","doi":"10.1016/j.lungcan.2017.04.016","title":"Uncommon EGFR mutations in advanced non-small cell lung cancer","year":2017,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Exon; Epidermal growth factor receptor; Point mutation; Lung cancer; Medicine; Cancer research; Mutation; Tyrosine kinase; Gefitinib; Gene; Genetics; Biology; Cancer; Oncology; Internal medicine; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.04008347259851398,"gpt":0.4348004016307965,"spread":0.3947169290322825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001147908,0.0007156984,0.002163444,0.0003961394,0.000267305,0.00008232752,0.0003725291,0.0004101035,0.0005570449],"category_scores_gemma":[0.00002888688,0.0005823736,0.0005646922,0.0004224557,0.00007975487,0.0001799375,0.00009365442,0.0007325686,0.00003725293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003454944,"about_ca_system_score_gemma":0.004058841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004500803,"about_ca_topic_score_gemma":0.005807239,"domain_scores_codex":[0.9972989,0.00006721431,0.0008049636,0.0008516773,0.0003232089,0.0006540471],"domain_scores_gemma":[0.9976869,0.0001186583,0.000715182,0.001039174,0.000169802,0.0002702458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002977339,0.0002484394,0.00604914,0.03546218,0.001114383,0.0001921805,0.0007538408,0.000185299,0.000002297696,0.00002782698,0.006268657,0.949666],"study_design_scores_gemma":[0.002494255,0.00005760295,0.0008687702,0.04244018,0.009350734,0.00001367568,0.00004551241,0.000191078,0.000006591406,0.000008592909,0.9439292,0.0005938275],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002120684,0.973859,0.00003741288,0.0002800591,0.001760762,0.003826857,0.0005942669,0.00007860945,0.01935097],"genre_scores_gemma":[0.0004060653,0.967181,0.000392868,0.0001842868,0.000628839,0.006762262,0.0006497035,0.0001803052,0.02361472],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9490722,"threshold_uncertainty_score":0.9996628,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2325642881","doi":"10.1016/j.lungcan.2016.04.004","title":"EGFR mutation status on brain metastases from non-small cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Oncology; Internal medicine; Lung cancer; Incidence (geometry); Clinical endpoint; Brain metastasis; Cumulative incidence; Epidermal growth factor receptor; Multivariate analysis; Population; Cancer; Metastasis; Cohort; Clinical trial","retraction":null,"screen_n_in":null,"score":{"opus":0.01181941927727326,"gpt":0.3313313429954913,"spread":0.319511923718218,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006217025,0.0002715071,0.0003360245,0.0001163155,0.0001174416,0.00003101751,0.00008119498,0.00008962547,0.002651991],"category_scores_gemma":[0.00004214821,0.0001593159,0.0001257808,0.0001882206,0.00004754058,0.0001436618,0.00002443629,0.0001171354,0.00005621241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001353367,"about_ca_system_score_gemma":0.0007136854,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01023459,"about_ca_topic_score_gemma":0.002011777,"domain_scores_codex":[0.998412,0.00004642448,0.0002723264,0.0004993932,0.0003090084,0.0004608377],"domain_scores_gemma":[0.998805,0.0002916652,0.0001506145,0.0003614755,0.0001385416,0.0002526441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.001416345,0.0009947759,0.334201,0.0006727481,0.004027733,0.0003740586,0.006627415,0.001246955,0.04921831,0.0003944236,0.3816364,0.2191899],"study_design_scores_gemma":[0.04595145,0.001390219,0.3814625,0.005888097,0.01218842,0.00001472735,0.00105057,0.004364179,0.1791933,0.0004512571,0.365932,0.002113392],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9482478,0.01252522,0.003675225,0.01829334,0.001966025,0.001950354,0.00333656,0.0002084274,0.009796978],"genre_scores_gemma":[0.9684246,0.00146684,0.001092229,0.004754491,0.0008166329,0.001059842,0.0002777874,0.00009084172,0.02201673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2170765,"threshold_uncertainty_score":0.9982597,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019407271","doi":"10.1016/j.lungcan.2004.08.016","title":"Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer","year":2004,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Vinorelbine; Chemotherapy; Lung cancer; Internal medicine; Surgery; Cohort; Cancer; Oncology; Cisplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.02556108665151988,"gpt":0.3682756082222771,"spread":0.3427145215707572,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001030011,0.001050707,0.003093898,0.0002327565,0.00009792853,0.00005799213,0.0002918985,0.0003790381,0.0008771375],"category_scores_gemma":[0.000004065451,0.0006983842,0.0004546467,0.0006499589,0.000105261,0.00009707172,0.00005633566,0.0008046993,0.00003066365],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007189518,"about_ca_system_score_gemma":0.0041099,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006334802,"about_ca_topic_score_gemma":0.004652547,"domain_scores_codex":[0.9967605,0.00006684911,0.0007272574,0.001209158,0.0004411084,0.0007951554],"domain_scores_gemma":[0.9981722,0.00008096771,0.0004570133,0.0007498982,0.0002517895,0.0002881446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005303053,0.001703117,0.02789739,0.2135806,0.003986993,0.001046135,0.002744689,0.0003599286,0.000005926895,0.00004798234,0.006762709,0.7413342],"study_design_scores_gemma":[0.01052352,0.0006723257,0.004642978,0.3887958,0.006372598,0.00006302373,0.00006369366,0.000117877,0.00009889965,0.000002115652,0.5871523,0.001494887],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005449727,0.9904469,0.00002488896,0.0009137906,0.0005546116,0.005375123,0.000410035,0.00006644953,0.001663241],"genre_scores_gemma":[0.0007586897,0.9867735,0.0004057263,0.001316053,0.0005512107,0.006843374,0.0002095126,0.0002500693,0.002891895],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7398393,"threshold_uncertainty_score":0.9995467,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2611025812","doi":"10.1016/j.lungcan.2017.04.021","title":"Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Propensity score matching; Radiation therapy; Chemotherapy; Lung cancer; Oncology; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03873701686102035,"gpt":0.3714446377825013,"spread":0.332707620921481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004310796,0.0002755579,0.001328852,0.0002206999,0.0002855736,0.00007824015,0.0001717047,0.0001026287,0.00006267977],"category_scores_gemma":[0.0001216136,0.0002294307,0.000217235,0.0002497286,0.000341837,0.0001511647,0.00008375029,0.0001675614,9.880483e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003431333,"about_ca_system_score_gemma":0.0004543796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004323998,"about_ca_topic_score_gemma":0.003564793,"domain_scores_codex":[0.9982465,0.0000454624,0.0003278307,0.0005507239,0.0003534434,0.0004760783],"domain_scores_gemma":[0.9981231,0.0003742303,0.0003314937,0.0005977793,0.000375906,0.000197456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009662268,0.00008443223,0.9354464,0.001822862,0.007933772,0.0000121237,0.001679378,0.00006405559,0.01180039,0.00001683448,0.001081503,0.03039602],"study_design_scores_gemma":[0.01495453,0.0004548814,0.9589415,0.0006043954,0.003944175,0.000001096592,0.0001272888,0.009382363,0.007465178,0.000007514525,0.003623781,0.000493254],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9620175,0.03261461,0.0004574655,0.002562385,0.0003986331,0.001554638,0.0001206262,0.00003519883,0.0002389277],"genre_scores_gemma":[0.9559302,0.04061136,0.0008853292,0.0002390491,0.0002753656,0.0005899028,0.00001227208,0.00006948604,0.001387057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02990277,"threshold_uncertainty_score":0.9355912,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068558121","doi":"10.1016/j.lungcan.2006.10.006","title":"Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer","year":2006,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Medicine; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.009922891560607522,"gpt":0.2749822567279934,"spread":0.2650593651673858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007901806,0.0001374836,0.0003800959,0.00005641596,0.00003064137,0.000004020148,0.00003953971,0.00005388175,0.00003994926],"category_scores_gemma":[0.00001278541,0.0001124622,0.00003470361,0.0003231159,0.00006863353,0.0000775347,0.00002678048,0.0001240289,1.435731e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003118698,"about_ca_system_score_gemma":0.0001504827,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01916198,"about_ca_topic_score_gemma":0.01123063,"domain_scores_codex":[0.9990004,0.00001845431,0.0002401478,0.0002913688,0.0002435824,0.0002060832],"domain_scores_gemma":[0.9994221,0.00003030245,0.00008896673,0.0002175766,0.000180235,0.00006079615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00172652,0.00006753539,0.9642739,0.0003839564,0.00001532456,0.000005530389,0.0001614187,0.0004237324,0.00009820049,0.00000471527,0.00004025603,0.03279896],"study_design_scores_gemma":[0.002611241,0.00009747564,0.9952461,0.001109798,0.0001046453,7.670019e-7,0.00005704636,0.0001266062,0.0001966685,0.00001150965,0.0003062472,0.0001318654],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882059,0.008811518,0.00001059121,0.00007668888,0.0001679672,0.0006067146,0.00009323924,0.00002464443,0.002002719],"genre_scores_gemma":[0.999189,0.0002246261,0.0001291589,0.00005365568,0.00006934677,0.00007886433,0.00001857496,0.00002136222,0.0002153872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0326671,"threshold_uncertainty_score":0.9873695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1550684373","doi":"10.1016/j.lungcan.2015.04.007","title":"The incidence and clinical impact of bone metastases in non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Lung cancer; Spinal cord compression; Internal medicine; Incidence (geometry); Bone metastasis; Oncology; Retrospective cohort study; Cohort; Radiation therapy; Surgery; Cancer; Metastasis; Spinal cord","retraction":null,"screen_n_in":null,"score":{"opus":0.03881720652294452,"gpt":0.4250968914791137,"spread":0.3862796849561692,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004443703,0.0001188022,0.0003669175,0.00004191447,0.00003706892,0.000007729998,0.00004687635,0.00006727737,0.00003183042],"category_scores_gemma":[0.0000858784,0.00006949429,0.00007874443,0.0001488856,0.00008303772,0.00004834333,0.00003811221,0.0001887387,0.000001761439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003157247,"about_ca_system_score_gemma":0.001069237,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03802292,"about_ca_topic_score_gemma":0.01189973,"domain_scores_codex":[0.9989225,0.00006306815,0.0003773337,0.0001932199,0.0001673873,0.0002764656],"domain_scores_gemma":[0.9990744,0.0001686598,0.0001465775,0.0002166419,0.00009778437,0.0002959456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00046788,0.0001037868,0.9884228,0.0001282965,0.0001048352,0.00003399035,0.0002498997,0.0000210568,0.00002983271,0.000003038128,0.004539214,0.005895369],"study_design_scores_gemma":[0.004129228,0.0003330063,0.9919873,0.000315728,0.0003271011,0.000008604677,0.00005534163,0.002026288,0.0001829948,0.0000140357,0.0005388987,0.00008145644],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9535646,0.0446792,0.000006629703,0.0005799716,0.0002367095,0.0005013526,0.00003981922,0.000008196563,0.0003834846],"genre_scores_gemma":[0.9927977,0.006011571,0.000136188,0.0002657339,0.00008192895,0.00009192425,0.000004147858,0.0000138922,0.000596921],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03923306,"threshold_uncertainty_score":0.968383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984146948","doi":"10.1016/j.lungcan.2012.04.014","title":"National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China","year":2012,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"BC Cancer Agency; National Comprehensive Cancer Network","keywords":"Medicine; Docetaxel; Gefitinib; Erlotinib; Pemetrexed; Oncology; Internal medicine; Gemcitabine; Lung cancer; Guideline; Chemotherapy; Cancer; Epidermal growth factor receptor; Cisplatin; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02256977514883364,"gpt":0.3723394169480871,"spread":0.3497696417992535,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002384619,0.0001666576,0.0002879029,0.00006834161,0.0000637717,0.000006518632,0.00008675917,0.0000969442,0.0005002286],"category_scores_gemma":[0.00006914358,0.0001035596,0.0001085783,0.0002531196,0.00004962368,0.00006444824,0.00002575658,0.0001026694,0.000001359055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001580669,"about_ca_system_score_gemma":0.002610499,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0255867,"about_ca_topic_score_gemma":0.01674967,"domain_scores_codex":[0.9986464,0.00005046093,0.0002805256,0.0002000852,0.0004137417,0.0004087275],"domain_scores_gemma":[0.9991921,0.0001440727,0.0001215369,0.0001830205,0.0001718358,0.0001875028],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001530952,0.0005121109,0.9887219,0.000188821,0.0003138216,0.0000012053,0.001874771,0.0001441107,0.0001025943,0.00006863962,0.00457307,0.00334585],"study_design_scores_gemma":[0.004872843,0.00007683302,0.987089,0.0002782248,0.0003965781,0.000001826237,0.00003722945,0.002585934,0.001197214,0.000007492998,0.003345149,0.0001116261],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752336,0.01325194,0.0001630285,0.001486867,0.001340133,0.002019491,0.00105967,0.00001729362,0.005428002],"genre_scores_gemma":[0.9940268,0.0008868562,0.0001562479,0.000351679,0.0003262432,0.001235456,0.0001184854,0.00002969846,0.002868562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0187932,"threshold_uncertainty_score":0.980902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998447850","doi":"10.1016/j.lungcan.2009.03.030","title":"Lung cancer screening using low-dose computed tomography in at-risk individuals: The Toronto experience","year":2009,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Lung cancer screening; Lung cancer; Nodule (geology); Stage (stratigraphy); Radiology; Cancer; Nuclear medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01773111948559597,"gpt":0.3445140233105349,"spread":0.3267829038249389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001846577,0.0003244596,0.0004538258,0.00009143403,0.0002830269,0.00005644183,0.0002112389,0.0001134357,0.0005638881],"category_scores_gemma":[0.00001401097,0.000229868,0.0001794176,0.0004970629,0.00008680816,0.000227954,0.00008296063,0.0002418172,0.000001072839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002327532,"about_ca_system_score_gemma":0.0001897063,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02490802,"about_ca_topic_score_gemma":0.01093002,"domain_scores_codex":[0.9978825,0.00008576494,0.0003955131,0.0005644154,0.0004911103,0.0005807367],"domain_scores_gemma":[0.9989395,0.00008631587,0.0002053827,0.0004983101,0.00008644177,0.0001840707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001664087,0.0002053463,0.9659927,0.00007232865,0.0002918759,0.00003878135,0.005381828,0.002241678,0.0002055654,0.00003521797,0.002938353,0.02242994],"study_design_scores_gemma":[0.003556691,0.0001051769,0.9673628,0.001977605,0.0005774663,0.00001157785,0.0003739956,0.0215165,0.001425036,0.00001208825,0.002722829,0.0003582846],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9171939,0.0788986,0.0002465613,0.001456647,0.000507664,0.001079291,0.00006269765,0.00008269637,0.0004718919],"genre_scores_gemma":[0.9921377,0.003643322,0.0009719418,0.002205905,0.0004626456,0.0004241574,0.00001537936,0.00003472487,0.0001042269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07525527,"threshold_uncertainty_score":0.9815852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3012479383","doi":"10.1016/j.lungcan.2020.03.014","title":"EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study","year":2020,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Chemotherapy; Epidermal growth factor receptor; Brain metastasis; Metastasis; Medical record; Exon; Cancer; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01448363717982595,"gpt":0.3474446239985959,"spread":0.33296098681877,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00003689431,0.0003383094,0.0004809505,0.0001570909,0.0001208158,0.00003625587,0.00007266398,0.00006453888,0.00009134375],"category_scores_gemma":[0.00002321196,0.0002562617,0.000095534,0.0005168731,0.00002620731,0.0001910204,0.00004039646,0.0001409913,0.000003658694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001388967,"about_ca_system_score_gemma":0.0002609879,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01804933,"about_ca_topic_score_gemma":0.05911162,"domain_scores_codex":[0.9982665,0.00006342721,0.0004919141,0.0006202983,0.0002722712,0.0002855782],"domain_scores_gemma":[0.9991241,0.00005505908,0.0001821364,0.0002462212,0.0001503887,0.0002421675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002231759,0.0009046911,0.9860609,0.00009045121,0.0004016286,0.00004160988,0.005095748,0.00280464,0.001855621,0.000002429764,0.0000486398,0.002470526],"study_design_scores_gemma":[0.01121273,0.0004324331,0.9799277,0.0001117529,0.00107757,2.226402e-7,0.0002900429,0.004967694,0.001493357,0.000008272013,0.0002178594,0.0002604013],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924636,0.001647434,0.0001385932,0.001637825,0.0002841679,0.002892525,0.0003620486,0.00007153875,0.0005022607],"genre_scores_gemma":[0.9953809,0.0004448974,0.0003942293,0.0008976193,0.0001276111,0.001886563,0.0004439012,0.00005451187,0.0003697653],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04106229,"threshold_uncertainty_score":0.999989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060209568","doi":"10.1016/s0169-5002(03)00308-8","title":"Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer","year":2003,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Angiogenesis; Medicine; Endostatin; Angiostatin; Lung cancer; Vascular endothelial growth factor; Pharmacology; Matrix metalloproteinase inhibitor; Matrix metalloproteinase; Cancer research; Sulindac; Immunology; Internal medicine; VEGF receptors","retraction":null,"screen_n_in":null,"score":{"opus":0.02280121020639448,"gpt":0.3541734399218214,"spread":0.331372229715427,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004163364,0.0006188334,0.001794966,0.0001399925,0.000057514,0.000009884288,0.00046574,0.000397639,0.00017309],"category_scores_gemma":[0.0000248896,0.00040657,0.001595576,0.0007093361,0.00009922209,0.000004930656,0.00005162356,0.00007418207,9.112226e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002802054,"about_ca_system_score_gemma":0.0008491603,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005810717,"about_ca_topic_score_gemma":0.0001337599,"domain_scores_codex":[0.9969887,0.0003927005,0.001171109,0.0006711308,0.000329636,0.0004467006],"domain_scores_gemma":[0.9980488,0.00005054151,0.0009257902,0.0007359909,0.0001719314,0.00006693337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004378496,0.0004985486,0.004945644,0.1803818,0.003003833,0.00001331238,0.000226633,0.00006716176,0.0007297793,0.0000216072,0.05159213,0.7584758],"study_design_scores_gemma":[0.0002517006,0.0001129143,0.00002191995,0.04160207,0.002715333,0.000005418629,0.00001848664,0.000004189376,0.0008222071,3.961612e-7,0.9540297,0.0004155952],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000287306,0.9968151,0.00001339765,0.00004457121,0.0004940465,0.001690773,0.0004820034,0.000005525175,0.0001672641],"genre_scores_gemma":[0.00008863973,0.9959077,0.00006760497,0.0002573699,0.0006653199,0.002384711,0.000238401,0.00009767967,0.0002926114],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9024376,"threshold_uncertainty_score":0.9998386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976487567","doi":"10.1016/j.lungcan.2012.02.019","title":"Emphysema detected on computed tomography and risk of lung cancer: A systematic review and meta-analysis","year":2012,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lung cancer; Meta-analysis; Odds ratio; Cochrane Library; Lung cancer screening; Internal medicine; Lung; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.04412811388537274,"gpt":0.3810135198853568,"spread":0.336885405999984,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006521093,0.0007720027,0.01082548,0.0008547161,0.00009867424,0.0000282109,0.0002526756,0.00025304,0.0008725162],"category_scores_gemma":[0.0001026239,0.0005009993,0.002796855,0.002355142,0.0002106958,0.00007811705,0.0001728726,0.0006495679,0.000002669605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000565752,"about_ca_system_score_gemma":0.0004655132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001042051,"about_ca_topic_score_gemma":0.0001953204,"domain_scores_codex":[0.995518,0.0009987465,0.001272352,0.0008703977,0.0008088228,0.0005317333],"domain_scores_gemma":[0.9962437,0.000480101,0.001276532,0.001148281,0.0003728301,0.0004786239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00001350804,0.00005354577,0.0009962354,0.729207,0.2614598,0.00001124788,0.00002392293,0.000001026739,8.415201e-8,0.000006838542,0.000152279,0.008074537],"study_design_scores_gemma":[0.0002728055,0.00002986082,0.001528751,0.1155614,0.8785551,0.00001938542,0.000004049715,0.0002376309,4.76037e-7,0.000001347377,0.003432953,0.0003561673],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005437063,0.9906071,0.0000146346,0.00006907374,0.00006665979,0.007254152,0.001820542,0.0000463474,0.00006711249],"genre_scores_gemma":[0.0003085535,0.9958854,0.000055451,0.00009401853,0.0001039945,0.002981597,0.0001174933,0.00009144718,0.0003620338],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6170954,"threshold_uncertainty_score":0.9997442,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2032371685","doi":"10.1016/j.lungcan.2005.06.010","title":"Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline","year":2005,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; Cancer Care Ontario","funders":"European Society for Medical Oncology","keywords":"Docetaxel; Taxane; Medicine; Oncology; Vinorelbine; Gemcitabine; Internal medicine; Lung cancer; Cisplatin; Paclitaxel; Guideline; Chemotherapy; Regimen; Cancer; Breast cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03023985746042535,"gpt":0.4431672683192456,"spread":0.4129274108588202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004838364,0.000887373,0.004322344,0.0001605289,0.0002155183,0.00005882424,0.0002384398,0.0002951493,0.0003222453],"category_scores_gemma":[0.0003757316,0.0006012859,0.0006352215,0.0004196534,0.00004515819,0.000195837,0.00005254479,0.0003472237,0.00001271223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001294583,"about_ca_system_score_gemma":0.002085456,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005704049,"about_ca_topic_score_gemma":0.0002290444,"domain_scores_codex":[0.9964108,0.0001383833,0.001651433,0.0009059788,0.0003499263,0.0005434741],"domain_scores_gemma":[0.9957992,0.0007433943,0.001658944,0.0008209367,0.0006915444,0.0002860065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006679964,0.0001652479,0.000003986607,0.8115799,0.002524061,0.00002078749,0.0001690571,0.00001357686,4.408548e-7,0.000009849701,0.0206803,0.1647659],"study_design_scores_gemma":[0.001716387,0.0001595404,2.645527e-7,0.341141,0.05257552,0.0001023192,0.00002124738,0.00006857872,0.000001130399,0.000001245699,0.6038538,0.0003589656],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001131357,0.9691408,0.0003237319,0.004371535,0.0005178992,0.02373694,0.0005889472,0.0000907888,0.001228286],"genre_scores_gemma":[0.000001721293,0.949279,0.003282808,0.007114172,0.0008913506,0.02786761,0.000492415,0.0002101886,0.01086079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5831735,"threshold_uncertainty_score":0.9996439,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060696690","doi":"10.1016/j.lungcan.2013.11.020","title":"Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Merck Sharp and Dohme","keywords":"Medicine; Erlotinib; Internal medicine; Neutropenia; Oncology; Lung cancer; Adverse effect; Surgery; Cancer; Epidermal growth factor receptor; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.009580312840794003,"gpt":0.2976431150917498,"spread":0.2880628022509558,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002262297,0.0004329357,0.001067783,0.000146339,0.00009520655,0.00002482737,0.0002970542,0.0001076987,0.0005708982],"category_scores_gemma":[0.0000531396,0.0002698772,0.0001641382,0.0004598594,0.0001831878,0.0002151642,0.000128974,0.0004563308,0.000004706781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007136589,"about_ca_system_score_gemma":0.0003442752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005714357,"about_ca_topic_score_gemma":0.001863826,"domain_scores_codex":[0.997247,0.0001898348,0.0007124066,0.0005867099,0.0007161128,0.0005478832],"domain_scores_gemma":[0.9980309,0.0002015215,0.0005078805,0.0007205385,0.0003609029,0.0001782632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2773912,0.004462022,0.6978638,0.0005351587,0.0008956105,0.00001795597,0.007144295,0.00133556,0.001844974,0.000005092978,0.0003264945,0.008177772],"study_design_scores_gemma":[0.8903041,0.0009852032,0.09665453,0.0009962561,0.001105928,7.233725e-7,0.001571974,0.0009017686,0.006871242,0.000006985354,0.0001372718,0.0004640158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876316,0.001929677,0.00004281231,0.0002946352,0.001312217,0.008305837,0.00005427971,0.00004602,0.0003828831],"genre_scores_gemma":[0.9952396,0.00008477559,0.0001229571,0.0002296794,0.0002914731,0.003122915,0.000009540511,0.0000962286,0.0008027866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6129129,"threshold_uncertainty_score":0.9999753,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966804257","doi":"10.1016/j.lungcan.2003.08.024","title":"Women’s susceptibility to tobacco carcinogens","year":2003,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Medicine; Odds ratio; Lung cancer; Confidence interval; Demography; Logistic regression; Smoking history; Incidence (geometry); Cohort; Tobacco control; Cohort study; Relative risk; Public health; Internal medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0248488492690046,"gpt":0.3287624544172703,"spread":0.3039136051482657,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001403196,0.00007598096,0.0001248983,0.00004075532,0.00004083741,0.000009422496,0.00003172221,0.00005034736,0.002772874],"category_scores_gemma":[0.00004937655,0.00006764114,0.00003571495,0.0001644225,0.00001367529,0.00002857201,0.000007809159,0.00008402153,0.00001078846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007780829,"about_ca_system_score_gemma":0.000118191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002311375,"about_ca_topic_score_gemma":0.0001081479,"domain_scores_codex":[0.9992814,0.00001980719,0.0001027129,0.0001966883,0.0001812442,0.0002181342],"domain_scores_gemma":[0.9995024,0.000009197311,0.00001838897,0.0002553737,0.00007066848,0.000143969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002924963,0.00003576112,0.9888126,0.00002054736,0.0000128702,0.000004240442,0.001129071,0.000008878375,0.003842687,0.00009210823,0.003214175,0.002797797],"study_design_scores_gemma":[0.0004483016,0.00006143805,0.9766045,0.00002733165,0.00005721254,0.000004205172,0.0003178532,0.000002966697,0.008890824,0.00001663875,0.01347646,0.00009222895],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995123,0.00009144346,0.00006096161,0.0003154396,0.0004778136,0.0002646505,0.000007278969,0.00004864685,0.003610728],"genre_scores_gemma":[0.9962901,0.000008894717,0.00005703328,0.0009608872,0.0001087472,0.00015823,0.000003668832,0.00001294014,0.002399432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01220808,"threshold_uncertainty_score":0.9981387,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163703503","doi":"10.1016/j.lungcan.2014.08.012","title":"Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors","year":2014,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Canadian Lung Association; American Society of Clinical Oncology; Uniting Against Lung Cancer; American Cancer Society","keywords":"Medicine; Carcinoid tumors; Etoposide; Octreotide; Internal medicine; Regimen; Chemotherapy; Gastroenterology; Progressive disease; Chemotherapy regimen; Neuroendocrine tumors; Surgery; Oncology; Somatostatin","retraction":null,"screen_n_in":null,"score":{"opus":0.01264226874378579,"gpt":0.3416283456782169,"spread":0.3289860769344312,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009307716,0.0001563903,0.0003141048,0.00007420422,0.00006343069,0.00001441337,0.00008131618,0.000005534019,0.00008581979],"category_scores_gemma":[0.0001270945,0.0001284981,0.00005835524,0.0001201059,0.00009537337,0.0001029232,0.00002792923,0.0001342476,0.000002761119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006857164,"about_ca_system_score_gemma":0.0001009758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005020188,"about_ca_topic_score_gemma":0.00003110822,"domain_scores_codex":[0.9988311,0.00003016216,0.0001714503,0.0003363954,0.0002364947,0.0003944297],"domain_scores_gemma":[0.9992763,0.0001372313,0.00005433514,0.0002343494,0.00009916107,0.0001985827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007781499,0.0005005219,0.1115739,0.007004016,0.0004643915,0.001270036,0.0003616566,0.0005132913,0.2137257,0.002183574,0.01166656,0.6429548],"study_design_scores_gemma":[0.03666931,0.00590087,0.1241801,0.002245005,0.0007468096,0.003349449,0.0005631869,0.1063211,0.2507366,0.006158818,0.4611696,0.001959068],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740837,0.008118734,0.003008237,0.00922789,0.0002452969,0.002578596,0.00003837054,0.0001573859,0.002541824],"genre_scores_gemma":[0.9886518,0.0005694965,0.004191451,0.002160766,0.0001842369,0.0005392501,0.00001016948,0.00006030154,0.003632516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6409958,"threshold_uncertainty_score":0.5239999,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069960588","doi":"10.1016/s0169-5002(02)00503-2","title":"Small stage I cancers of the lung: genuineness and curability","year":2003,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lung cancer; Stage (stratigraphy); Asymptomatic; Lymph node; Case fatality rate; Cancer; Lung; Mediastinal lymph node; Surgery; Epidemiology; Radiology; Internal medicine; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.01988283395626847,"gpt":0.3052485709424172,"spread":0.2853657369861488,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001121452,0.0001337528,0.0002540787,0.00002115143,0.00006068441,0.000007957769,0.0000613071,0.00005214818,0.0003262634],"category_scores_gemma":[0.00003721774,0.00008316705,0.00008603764,0.0001561951,0.0001099377,0.00002986285,0.00002523879,0.00009739027,4.969788e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000780755,"about_ca_system_score_gemma":0.000459583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002371438,"about_ca_topic_score_gemma":0.0009908273,"domain_scores_codex":[0.9991516,0.00004598036,0.0001805605,0.0002588616,0.0001696612,0.0001933108],"domain_scores_gemma":[0.999299,0.00004770497,0.00009013766,0.0003909131,0.00008105882,0.00009117153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005486555,0.00007683528,0.9937331,0.0006208939,0.0002015996,0.000003623109,0.0004043997,0.0001076768,0.0002573789,0.0009327038,0.002325245,0.001281646],"study_design_scores_gemma":[0.003919321,0.0001397195,0.9130707,0.0007324837,0.0009463492,0.00001075301,0.0001819637,0.0004526082,0.03092387,0.00009726195,0.04926405,0.0002609261],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9768392,0.01773565,0.00001839461,0.001228126,0.0004856522,0.0006564649,0.0000571418,0.00001700912,0.002962331],"genre_scores_gemma":[0.9962817,0.001393318,0.00009075128,0.0004352393,0.0000571717,0.0001843261,0.000001969438,0.00001694323,0.001538514],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08066244,"threshold_uncertainty_score":0.358492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097463411","doi":"10.1016/j.lungcan.2012.05.111","title":"A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma","year":2012,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Columbia College","funders":"National Cancer Institute","keywords":"Medicine; Pemetrexed; Bevacizumab; Clinical endpoint; Internal medicine; Mesothelioma; Neutropenia; Progression-free survival; Oncology; Vascular endothelial growth factor; Gastroenterology; Cisplatin; Phases of clinical research; Survival rate; Chemotherapy; Surgery; Pathology; Clinical trial; VEGF receptors","retraction":null,"screen_n_in":null,"score":{"opus":0.006440750221946768,"gpt":0.2942190817725004,"spread":0.2877783315505536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003020307,0.00009893138,0.0001690335,0.00006753767,0.00003037998,0.000001831403,0.00002367223,0.00001767564,0.0001858635],"category_scores_gemma":[0.000006325633,0.00006886201,0.00001618148,0.00009621782,0.00002901889,0.0001143568,0.000035067,0.00004096655,0.000001153182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007789791,"about_ca_system_score_gemma":0.00001118028,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001000822,"about_ca_topic_score_gemma":0.00004211981,"domain_scores_codex":[0.9993159,0.00001419411,0.0001523561,0.0001365095,0.0002296473,0.0001514642],"domain_scores_gemma":[0.9997006,0.00001352264,0.00006250976,0.0001093635,0.00001981796,0.00009416766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005123747,0.005282344,0.9808899,0.00007993176,0.00006950043,0.000002713752,0.0008128893,0.0000114759,0.0003254252,0.000002613344,0.0000338084,0.007365669],"study_design_scores_gemma":[0.01882591,0.002587424,0.9774271,0.0001589422,0.0001677493,4.877878e-7,0.0003177093,0.00009086507,0.0002619507,4.631908e-7,0.00007965448,0.00008174867],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981574,0.0009773161,0.000001971215,0.00002332653,0.00004656528,0.0006510865,0.00005809525,0.00000685099,0.00007739901],"genre_scores_gemma":[0.9995394,0.00002130464,0.0001283098,0.00007649129,0.00002499743,0.00007532589,0.00002326227,0.00001322416,0.00009763565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01370216,"threshold_uncertainty_score":0.2808111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965527358","doi":"10.1016/s0169-5002(01)00397-x","title":"Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer","year":2001,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Notre-Dame; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Decitabine; Epigenetics; DNA methylation; Lung cancer; Medicine; Carcinogenesis; Deoxycytidine; Cancer research; Methylation; Epigenetic therapy; Cancer; Oncology; Gene; Biology; Internal medicine; Gene expression; Genetics; Gemcitabine","retraction":null,"screen_n_in":null,"score":{"opus":0.008718673126525666,"gpt":0.2836352383365898,"spread":0.2749165652100641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001798603,0.0001742053,0.0003008489,0.00007390962,0.0000343664,0.000004568345,0.0001382082,0.0001630486,0.0000341397],"category_scores_gemma":[0.00002208405,0.000164306,0.0001902477,0.0001508233,0.00004657967,0.000007034395,0.00004054709,0.00005220313,8.314152e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003787161,"about_ca_system_score_gemma":0.0001712235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002250323,"about_ca_topic_score_gemma":0.0001007247,"domain_scores_codex":[0.9988018,0.00003503212,0.0004728562,0.0003010744,0.000176918,0.0002123691],"domain_scores_gemma":[0.9987761,0.00002034653,0.0004413889,0.0002765848,0.000432158,0.00005344598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005569303,0.0001043071,0.009097094,0.0001924976,0.000105451,2.561309e-7,0.0001169666,0.01141175,0.9656854,0.000007578858,0.0001105698,0.01261118],"study_design_scores_gemma":[0.002117203,0.0003416665,0.01126727,0.00007531962,0.00007646206,2.008668e-7,0.00003753864,0.002789721,0.9814067,0.00004097681,0.001677586,0.0001693786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9491618,0.02775417,0.02164028,0.00007518564,0.00039584,0.0006942447,0.0001356151,0.000004363982,0.0001385323],"genre_scores_gemma":[0.9842992,0.01268399,0.002113185,0.00002690198,0.000330363,0.0001429456,0.00008952657,0.00003525388,0.0002786739],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03513739,"threshold_uncertainty_score":0.6700203,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009482902","doi":"10.1016/j.lungcan.2006.04.007","title":"Risk of lung cancer following nonmalignant respiratory conditions: Evidence from two case-control studies in Montreal, Canada","year":2006,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Université de Montréal; Institut National de la Recherche Scientifique; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Odds ratio; Context (archaeology); Respiratory disease; Asthma; Internal medicine; Pneumonia; Case-control study; Cancer; Confounding; Population; Risk factor; Lung; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.02421435886506736,"gpt":0.3660302176867448,"spread":0.3418158588216774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003240309,0.0002854492,0.0007180713,0.0001718851,0.0001585066,0.00001315751,0.0001540512,0.00007467929,0.0004588087],"category_scores_gemma":[0.0003065844,0.0002583582,0.0001754675,0.0004237101,0.0001914094,0.0002228671,0.00007125233,0.0003614546,0.000001455342],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004395642,"about_ca_system_score_gemma":0.00289761,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.982367,"about_ca_topic_score_gemma":0.9835283,"domain_scores_codex":[0.9972467,0.000249998,0.0006112377,0.0005861887,0.0007310421,0.0005747855],"domain_scores_gemma":[0.99795,0.0008264985,0.0002435956,0.0004944037,0.0003038474,0.0001816903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003003547,0.00005780089,0.9722402,0.000554705,0.001079752,0.006414835,0.0002965746,0.005048393,0.001715274,0.000008456907,0.01114134,0.001142313],"study_design_scores_gemma":[0.004972334,0.00002984617,0.9758604,0.00360543,0.001586955,0.0000230823,0.0006928612,0.01177494,0.0008409495,0.00009177896,0.0002110756,0.0003103921],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7421809,0.254495,0.00001175524,0.0003052495,0.0004565553,0.0008800252,0.001523425,0.00001980154,0.0001273327],"genre_scores_gemma":[0.9961403,0.001884938,0.00002918443,0.0002493235,0.0005855318,0.0006679941,0.00001752451,0.00004216333,0.0003830209],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2539594,"threshold_uncertainty_score":0.9999869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2544627141","doi":"10.1016/j.lungcan.2016.10.011","title":"Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial","year":2016,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; Boehringer Ingelheim (Canada)","funders":"","keywords":"Pemetrexed; Medicine; Nintedanib; Internal medicine; Lung cancer; Hazard ratio; Placebo; Clinical endpoint; Oncology; Bevacizumab; Gastroenterology; Chemotherapy; Surgery; Randomized controlled trial; Confidence interval; Lung; Idiopathic pulmonary fibrosis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02024304551739279,"gpt":0.3488162317950362,"spread":0.3285731862776434,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004350643,0.0008850746,0.002049758,0.0006366335,0.0002378641,0.00006972992,0.0003364536,0.0003369592,0.001956149],"category_scores_gemma":[0.0001862114,0.0005321265,0.0003985378,0.001081436,0.0002134762,0.0005106374,0.00009992493,0.000542357,0.00001721912],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006582998,"about_ca_system_score_gemma":0.003516696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004556204,"about_ca_topic_score_gemma":0.005819619,"domain_scores_codex":[0.9951469,0.0002023445,0.001228384,0.001293254,0.0009987602,0.001130328],"domain_scores_gemma":[0.9963956,0.0007477094,0.0008394782,0.0008968005,0.0005832249,0.000537133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9787383,0.00126733,0.005004304,0.000347928,0.002161305,0.000103421,0.002036108,0.0003321663,0.0002146505,0.00001426826,0.003592357,0.006187828],"study_design_scores_gemma":[0.9845324,0.002291458,0.0005540967,0.001950771,0.004903915,0.000001971387,0.0002682986,0.002173174,0.0007990851,0.000001552933,0.001730748,0.0007924984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683908,0.004561143,0.001155256,0.0006685322,0.003833828,0.01735032,0.0003219633,0.0002081012,0.003510011],"genre_scores_gemma":[0.9674566,0.001346603,0.0006729428,0.0002536439,0.0007032523,0.009671536,0.0002835212,0.0002298836,0.01938197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01587196,"threshold_uncertainty_score":0.999713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1679349094","doi":"10.1016/j.lungcan.2015.07.001","title":"Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer","year":2015,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gemcitabine; Vinorelbine; Toxicity; Common Terminology Criteria for Adverse Events; Chemotherapy; Lung cancer; Internal medicine; Lean body mass; Chemotherapy regimen; Regimen; Oncology; Gastroenterology; Surgery; Urology; Cisplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.03323948792599945,"gpt":0.3422419903377314,"spread":0.3090025024117319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002477024,0.0002309679,0.0005705897,0.0001027427,0.00006582514,0.00001774803,0.0001097243,0.000210536,0.0004698709],"category_scores_gemma":[0.0000322355,0.0001885817,0.00006001504,0.0004214977,0.00003767724,0.00008383099,0.00002057483,0.0004583211,0.000006044815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001139337,"about_ca_system_score_gemma":0.0006394754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005903264,"about_ca_topic_score_gemma":0.001065804,"domain_scores_codex":[0.9982954,0.00005396385,0.0003379302,0.0004230076,0.0003384078,0.0005513451],"domain_scores_gemma":[0.9989941,0.00004676743,0.0001681037,0.000240649,0.0002106048,0.0003398501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001259979,0.0008893703,0.92862,0.001633738,0.0001425221,0.0003121938,0.004602817,0.0002175981,0.03933524,0.00002397267,0.01884185,0.004120678],"study_design_scores_gemma":[0.06823885,0.001186881,0.5835391,0.01226194,0.0004332614,0.00003551977,0.001771156,0.05172512,0.2698267,0.0001891434,0.008826326,0.001966102],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878594,0.00145127,0.0001996873,0.006603482,0.0003395543,0.0009632728,0.00002361936,0.0001065764,0.002453178],"genre_scores_gemma":[0.9862883,0.0003917825,0.0008534432,0.01078556,0.0001702087,0.0003490596,0.00001305575,0.00004658221,0.001102008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.345081,"threshold_uncertainty_score":0.7690139,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989531033","doi":"10.1016/j.lungcan.2011.05.009","title":"Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: Interrelations and associations with prognosis","year":2011,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"China Academy of Building Research","keywords":"Medicine; Internal medicine; Adiponectin; Cachexia; Leptin; Gastroenterology; Lung cancer; Cancer; Ghrelin; Context (archaeology); Oncology; Insulin; Obesity; Insulin resistance; Hormone","retraction":null,"screen_n_in":null,"score":{"opus":0.03305584892285819,"gpt":0.3659825178433134,"spread":0.3329266689204552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001067096,0.00009109384,0.0002163728,0.000130579,0.00004828654,0.000006271701,0.00002305784,0.00004412637,0.0002032445],"category_scores_gemma":[0.00002188274,0.00008041678,0.00002119516,0.0001822381,0.00007959438,0.0000790775,0.00001735553,0.0001577005,1.017609e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002934179,"about_ca_system_score_gemma":0.0001811647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006995241,"about_ca_topic_score_gemma":0.0003641814,"domain_scores_codex":[0.9992049,0.00003465105,0.0002580889,0.0001752473,0.0001756645,0.0001514029],"domain_scores_gemma":[0.9995218,0.00006189958,0.0001204218,0.00005731652,0.0001391331,0.00009946303],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001134736,0.0003301179,0.9956765,0.0005606244,0.0001280033,0.000001567512,0.0006793933,5.933645e-7,0.0001030707,0.0002316021,0.001893798,0.0002812303],"study_design_scores_gemma":[0.002926875,0.0001132215,0.9933653,0.001171047,0.0002602398,0.000002092758,0.0002063018,0.001495544,0.0001967293,0.00005714307,0.0001154851,0.00009002203],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937828,0.002508133,0.00009597127,0.001904353,0.00007211371,0.0007236381,0.0001981366,0.00001433978,0.0007005172],"genre_scores_gemma":[0.9920321,0.0004979933,0.00652536,0.0003382755,0.00002508295,0.0004562497,0.00006807517,0.00001193302,0.00004499148],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006429389,"threshold_uncertainty_score":0.3279301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114472079","doi":"10.1016/j.lungcan.2009.08.020","title":"Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates","year":2009,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Zoledronic acid; Lung cancer; Internal medicine; Placebo; Quality of life (healthcare); Oncology; Incidence (geometry); Cancer; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02663971384376639,"gpt":0.3522191054764546,"spread":0.3255793916326882,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001050725,0.0006259144,0.00171335,0.0001209298,0.0001833902,0.0000422743,0.00006982429,0.0001698493,0.00003391659],"category_scores_gemma":[0.00001305043,0.0003016074,0.0001812326,0.0003895276,0.00009100047,0.00009631061,0.00001682451,0.0002784116,5.882469e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001051183,"about_ca_system_score_gemma":0.001114519,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0188952,"about_ca_topic_score_gemma":0.0124264,"domain_scores_codex":[0.9979384,0.00007779605,0.000512585,0.0005946602,0.0003027265,0.0005738628],"domain_scores_gemma":[0.9986941,0.0002599869,0.0004098678,0.0002982332,0.0001031155,0.0002346981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002501742,0.0003752664,0.2544202,0.005393154,0.001066253,0.00003678793,0.0001346447,0.000001669726,1.322869e-8,0.000004520826,0.0002328268,0.7380846],"study_design_scores_gemma":[0.03109003,0.008593326,0.1672701,0.09573074,0.04361991,0.00006389079,0.00008357193,0.0002713269,0.00001503349,0.000007242124,0.6514084,0.001846408],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03750899,0.9542723,0.000004217305,0.00028518,0.0001035207,0.006983506,0.0007771368,0.00003052217,0.00003467624],"genre_scores_gemma":[0.009804603,0.9776577,0.0003717774,0.0002255206,0.00007779198,0.01127211,0.0002777645,0.00008251503,0.0002302417],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7362381,"threshold_uncertainty_score":0.9999436,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054887777","doi":"10.1016/j.lungcan.2014.04.005","title":"Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer","year":2014,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute","keywords":"Platinum; Medicine; Lung cancer; Chemotherapy; Immunohistochemistry; Oncology; Internal medicine; Cancer; Pathology; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.008513368554682004,"gpt":0.2763658677077164,"spread":0.2678524991530344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001123542,0.0001969194,0.0003338517,0.00004545585,0.0000567248,0.0000239308,0.00006053452,0.00014543,0.0007495122],"category_scores_gemma":[0.000003324952,0.0001660318,0.00004287891,0.0001231086,0.00004242297,0.0001095179,0.0000113177,0.0002085384,0.000002576882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001826734,"about_ca_system_score_gemma":0.0001067709,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001085184,"about_ca_topic_score_gemma":0.0007871027,"domain_scores_codex":[0.9987697,0.00003124591,0.0002844767,0.0003876175,0.0002029536,0.0003239978],"domain_scores_gemma":[0.9995027,0.00002468308,0.00008858881,0.0001852322,0.00005737935,0.0001414831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002228081,0.00008554028,0.8048971,0.0008443977,0.00003009788,0.000007441539,0.002680125,0.0001796422,0.1653104,0.00001570409,0.01086285,0.01486397],"study_design_scores_gemma":[0.008854861,0.0002856473,0.4334597,0.003300473,0.0004732306,0.000004890965,0.0002169339,0.02810197,0.5015276,0.000008718685,0.02307488,0.0006910717],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873627,0.006644767,0.0007160654,0.0009391967,0.0004055042,0.0007544918,0.00002319306,0.00003551177,0.003118526],"genre_scores_gemma":[0.9950728,0.001747124,0.0002406154,0.001136662,0.0003404024,0.0004424378,0.00002020715,0.00003638251,0.0009633079],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3714374,"threshold_uncertainty_score":0.8206633,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2260636514","doi":"10.1016/j.lungcan.2016.01.021","title":"Leisure-time physical activity and lung cancer risk: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Physical Activity and Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Canadian Cancer Society Research Institute; Alberta Innovates - Health Solutions; World Health Organization; Alberta Cancer Foundation; Cancer Research Institute","keywords":"Medicine; Relative risk; Lung cancer; Meta-analysis; Confidence interval; Confounding; Internal medicine; Population; Lower risk; Cancer; Oncology; Demography; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.07407870955170781,"gpt":0.4419348331831739,"spread":0.3678561236314661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005060227,0.0007040979,0.01734327,0.000159439,0.000145783,0.00003658955,0.0001441068,0.0002312989,0.0004880402],"category_scores_gemma":[0.0001099895,0.0003693953,0.002359048,0.0006752938,0.0001231785,0.0001728456,0.0001170532,0.0007473962,0.00002062873],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004814091,"about_ca_system_score_gemma":0.0005204027,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009467347,"about_ca_topic_score_gemma":0.0001264741,"domain_scores_codex":[0.9968864,0.0007361676,0.0005632302,0.0008925325,0.000467764,0.0004539069],"domain_scores_gemma":[0.9970153,0.0007015797,0.001043113,0.0007427582,0.0001093231,0.0003879367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000007850721,0.0001414308,0.000009651784,0.8298796,0.1560415,0.000004930547,0.0000287705,7.910261e-8,8.741665e-7,0.00001834913,0.0006246982,0.01324227],"study_design_scores_gemma":[0.0001587461,0.00003734243,0.00002185544,0.119589,0.8660033,0.000009422659,3.991635e-7,0.0001456678,8.461453e-7,0.000007204902,0.01367345,0.0003527096],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006349228,0.9935427,0.0000318684,0.0009939026,0.00003708445,0.004176375,0.0009683673,0.0000521915,0.0001340234],"genre_scores_gemma":[0.0002486414,0.9934316,0.00001016635,0.0002418133,0.0003186374,0.002634272,0.00001500879,0.00006317258,0.003036697],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7102906,"threshold_uncertainty_score":0.9998758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1983936911","doi":"10.1016/j.lungcan.2004.12.004","title":"Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?","year":2005,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Prophylactic cranial irradiation; Chemotherapy; Incidence (geometry); Lung cancer; Stage (stratigraphy); Surgery; Oncology; Brain metastasis; Internal medicine; Cancer; Metastasis","retraction":null,"screen_n_in":null,"score":{"opus":0.01071569521817513,"gpt":0.311923990686607,"spread":0.3012082954684319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002678949,0.0002122207,0.0003780498,0.0001037594,0.00008779742,0.00002443204,0.00008579617,0.00006910977,0.0001805588],"category_scores_gemma":[0.00008952518,0.0001066841,0.00007323522,0.0002690486,0.00007864509,0.0001694604,0.00003573379,0.0002225326,0.000001628967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003667305,"about_ca_system_score_gemma":0.0002556912,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004885448,"about_ca_topic_score_gemma":0.01801502,"domain_scores_codex":[0.9986305,0.00008937061,0.0004086197,0.0003361235,0.000261686,0.0002736487],"domain_scores_gemma":[0.9991151,0.0002215395,0.0002108017,0.0002596301,0.00009801071,0.00009492829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003374354,0.0005258179,0.7597442,0.002466788,0.0004253877,0.0001167682,0.00369341,0.008875084,0.01863778,0.00004260237,0.0002011874,0.2018966],"study_design_scores_gemma":[0.008739401,0.0007016073,0.9494818,0.0005341278,0.001504596,0.00002261735,0.0003679272,0.01744832,0.01921466,0.00001940465,0.00157471,0.0003908151],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898471,0.003687356,0.0007114283,0.003966138,0.0003034982,0.001359541,0.00006735435,0.00002190107,0.00003565671],"genre_scores_gemma":[0.9959152,0.0003931844,0.001449406,0.0007607323,0.0002327157,0.0004408448,0.000004015246,0.00002804923,0.0007758759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2015058,"threshold_uncertainty_score":0.9999036,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901525385","doi":"10.1016/j.lungcan.2018.11.024","title":"Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Ontario","funders":"National Key Research and Development Program of China; National Natural Science Foundation of China","keywords":"Crizotinib; Medicine; Lung cancer; Anaplastic lymphoma kinase; Cancer research; Tyrosine kinase; ALK inhibitor; Internal medicine; Concomitant; Oncology; Cancer; Tyrosine-kinase inhibitor; Receptor","retraction":null,"screen_n_in":null,"score":{"opus":0.008287191718323293,"gpt":0.3050793065326908,"spread":0.2967921148143675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000112222,0.0003280587,0.0004538342,0.0001916142,0.0001684526,0.00003658815,0.0001309246,0.0001324944,0.0003205261],"category_scores_gemma":[0.00003203855,0.0002895059,0.0001006647,0.0005780918,0.00007762679,0.0001153875,0.00006701743,0.0002074844,0.00002699073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001916082,"about_ca_system_score_gemma":0.0006505924,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006222432,"about_ca_topic_score_gemma":0.02781072,"domain_scores_codex":[0.9980613,0.00003749912,0.0003963921,0.0006347316,0.0002956823,0.0005744044],"domain_scores_gemma":[0.9987745,0.00007213592,0.0001342982,0.0003900786,0.0003137168,0.0003153098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004673711,0.001657105,0.3911313,0.001722973,0.001453664,0.0008615384,0.0328908,0.0007326637,0.3829322,0.001343914,0.170292,0.01030812],"study_design_scores_gemma":[0.02483472,0.00119337,0.1614398,0.008209374,0.002478297,0.00001125349,0.001454821,0.006275057,0.7451224,0.0001817758,0.04702652,0.001772555],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9397941,0.01514663,0.004356134,0.007167299,0.003304907,0.005096422,0.0008346083,0.0001784812,0.02412141],"genre_scores_gemma":[0.9808839,0.0002581236,0.003153957,0.002683348,0.0007077355,0.001228804,0.00004452094,0.00007879481,0.01096084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3621903,"threshold_uncertainty_score":0.9999557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166913932","doi":"10.1016/j.lungcan.2011.05.026","title":"Feasibility and preliminary efficacy of progressive resistance exercise training in lung cancer survivors","year":2011,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Canada Research Chairs","keywords":"Medicine; Physical therapy; Lung cancer; Quality of life (healthcare); Physical strength; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03817123558172534,"gpt":0.3299521405196466,"spread":0.2917809049379212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002671834,0.0002254656,0.0005492538,0.0001198334,0.00004794453,0.000008281131,0.0001203775,0.0001343725,0.000417278],"category_scores_gemma":[0.00005177705,0.0002062916,0.00009375785,0.0003930037,0.0001987801,0.0001195311,0.00005874947,0.0002623328,3.395582e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003155058,"about_ca_system_score_gemma":0.0004406231,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01106882,"about_ca_topic_score_gemma":0.05053819,"domain_scores_codex":[0.9983676,0.00006478446,0.0003902052,0.0005062109,0.0002924062,0.0003787561],"domain_scores_gemma":[0.9990381,0.00007360303,0.0001795666,0.0003931461,0.0001523476,0.0001632158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004368737,0.0001620029,0.915472,0.002267031,0.00008919579,0.00007572405,0.05489624,0.000007242624,0.0001450659,0.00008640159,0.0003296488,0.02210072],"study_design_scores_gemma":[0.00301428,0.0001344457,0.9850639,0.005111023,0.0004023062,0.000005379801,0.002657126,0.0002699565,0.002392726,0.00007420834,0.0005290558,0.0003455881],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9004362,0.09499267,0.00001206433,0.000164177,0.0004971409,0.001131966,0.00005579716,0.00004579725,0.002664237],"genre_scores_gemma":[0.9961503,0.002187998,0.0001492494,0.00008955554,0.0001208226,0.0004616757,0.000007178682,0.00003816686,0.0007950696],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09571413,"threshold_uncertainty_score":0.9955165,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068132555","doi":"10.1016/j.lungcan.2009.09.007","title":"The role of βIII tubulin in predicting chemoresistance in non-small cell lung cancer","year":2009,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Medicine; Taxane; Lung cancer; Oncology; Regimen; Internal medicine; Cancer; Disease; Chemotherapy; Bioinformatics; Breast cancer; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01054452523116147,"gpt":0.3455279647752142,"spread":0.3349834395440528,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000230659,0.0004609897,0.001528461,0.0002125138,0.00008769826,0.00002537,0.000274917,0.0002825109,0.00006902819],"category_scores_gemma":[0.00002895443,0.000315805,0.0003123283,0.0007254279,0.00006071476,0.00005921347,0.00005015644,0.0006337074,0.000002375127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002118841,"about_ca_system_score_gemma":0.001983064,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004385485,"about_ca_topic_score_gemma":0.007397053,"domain_scores_codex":[0.997563,0.00007061363,0.0009536475,0.0005492194,0.0003181509,0.0005453728],"domain_scores_gemma":[0.9985386,0.0001826033,0.0005443635,0.0005214933,0.0001020984,0.0001108838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009206837,0.0002554246,0.03911076,0.02244386,0.0005503648,0.00006215897,0.001446466,0.00009778945,0.00001604165,0.0000402707,0.001743726,0.9341411],"study_design_scores_gemma":[0.003004495,0.0000854208,0.005856481,0.07906321,0.004867775,0.000008629903,0.000269489,0.00122612,0.0001085857,0.00002709772,0.9048986,0.0005840363],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008371997,0.9879409,0.00000403539,0.0001622097,0.0003642175,0.002499009,0.0001399764,0.00002599842,0.008026466],"genre_scores_gemma":[0.00292988,0.9916735,0.00009850422,0.00009018617,0.0003792209,0.00190137,0.00007075959,0.00007980719,0.002776796],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.933557,"threshold_uncertainty_score":0.9999294,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2752034854","doi":"10.1016/j.lungcan.2017.09.002","title":"Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer","year":2017,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Toronto General Hospital","funders":"","keywords":"Medicine; Lung cancer; Folate receptor; In vivo; Lymph node; Cancer; Cancer research; Photodynamic therapy; Pathology; Lung; Cancer cell; Internal medicine; Biology; Chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01778566342411045,"gpt":0.3754112242279207,"spread":0.3576255608038102,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003017354,0.0003214541,0.0005691263,0.00008358437,0.000784318,0.0001027352,0.0004101508,0.0001234083,0.001131482],"category_scores_gemma":[0.0001611587,0.0002604783,0.00022071,0.0001241221,0.0002282621,0.0002508559,0.00009996294,0.0002644521,0.000007715362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007379701,"about_ca_system_score_gemma":0.0004404387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00147888,"about_ca_topic_score_gemma":0.0008799274,"domain_scores_codex":[0.997727,0.0000419766,0.0003163876,0.0005802005,0.0004042703,0.0009301646],"domain_scores_gemma":[0.9982201,0.00008909118,0.0002419412,0.0008697727,0.0003304249,0.0002486382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0025817,0.0001094091,0.006548649,0.0002217047,0.0009558286,0.000005113475,0.0007237142,0.00002949896,0.9643239,0.0000304358,0.009124987,0.01534507],"study_design_scores_gemma":[0.01275557,0.0006184904,0.03785342,0.0007135629,0.0002410731,0.000002551538,0.00009374354,0.03814982,0.8941917,0.0001181295,0.01461245,0.0006494535],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733622,0.01829693,0.0001947259,0.003338135,0.001203475,0.002726965,0.0002639376,0.0001533897,0.0004602593],"genre_scores_gemma":[0.9746613,0.01270204,0.0002580629,0.0007177779,0.0005127349,0.003606735,0.00002470157,0.00009643887,0.007420198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07013216,"threshold_uncertainty_score":0.9999847,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033412371","doi":"10.1016/j.lungcan.2004.11.003","title":"Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary","year":2005,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University; Cancer Care Ontario; Hamilton Health Sciences; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Mesothelioma; Extrapleural Pneumonectomy; Randomized controlled trial; Pneumonectomy; Pleural disease; Lung cancer; Clinical trial; Surgery; Pleurectomy; General surgery; Oncology; Internal medicine; Respiratory disease; Lung; Pathology; Peritoneal mesothelioma","retraction":null,"screen_n_in":null,"score":{"opus":0.03974358463808642,"gpt":0.3840163194289314,"spread":0.344272734790845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001703697,0.0002847702,0.002068237,0.00006306957,0.00002402847,0.000006164898,0.00011124,0.0000731502,0.0003499609],"category_scores_gemma":[0.00001128438,0.0001780336,0.0003519289,0.0001595236,0.00006593196,0.00005473671,0.0001023643,0.00009923433,0.00002006195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002375602,"about_ca_system_score_gemma":0.00007374038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001649065,"about_ca_topic_score_gemma":0.000001163593,"domain_scores_codex":[0.9983714,0.00009323091,0.0006838044,0.0003183018,0.0003689041,0.0001643595],"domain_scores_gemma":[0.9991121,0.00009730689,0.0003250224,0.0003228,0.00001711153,0.0001256706],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000150502,0.00004832611,0.0000945282,0.969609,0.0006565007,0.0001118131,0.000002998829,1.445638e-7,2.655235e-8,0.00004489936,0.001207464,0.0282092],"study_design_scores_gemma":[0.0001466252,0.00002765756,0.0001446758,0.8752984,0.02979495,0.0001267739,0.000002627064,0.000003393036,8.11487e-8,8.043274e-7,0.09429993,0.0001540491],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000004682282,0.9967098,6.463174e-7,0.0001258027,0.00004957587,0.002675079,0.0001004008,0.00001611028,0.0003179678],"genre_scores_gemma":[0.0000200144,0.9945617,0.00005339919,0.0001693229,0.00008566174,0.0007816728,0.00005123891,0.00002975742,0.004247222],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0943106,"threshold_uncertainty_score":0.7260001,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2899436946","doi":"10.1016/j.lungcan.2018.10.028","title":"Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)","year":2018,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Boehringer Ingelheim","keywords":"Medicine; Afatinib; Tolerability; Adverse effect; Internal medicine; Incidence (geometry); Medical record; Observational study; Oncology; Surgery; Epidermal growth factor receptor; Cancer; Gefitinib","retraction":null,"screen_n_in":null,"score":{"opus":0.008844275390835923,"gpt":0.3752341129827568,"spread":0.3663898375919209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009017377,0.0001813484,0.0003238386,0.00009352794,0.00006949076,0.00001025995,0.00004095945,0.0000390572,0.00001836274],"category_scores_gemma":[0.000039037,0.0001295724,0.0000364548,0.0004381523,0.00007265114,0.0001230575,0.00001384823,0.00007256298,0.000001537372],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001441881,"about_ca_system_score_gemma":0.0002532165,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02411525,"about_ca_topic_score_gemma":0.00612697,"domain_scores_codex":[0.9987802,0.00009995216,0.0002931753,0.0004063776,0.0002537702,0.0001665212],"domain_scores_gemma":[0.9989839,0.0001594869,0.0002034052,0.0002610865,0.0003070935,0.00008498882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03303633,0.001121272,0.9429465,0.0000241461,0.0006015926,0.000007096549,0.003342428,0.0007134755,0.00004779363,0.00004551972,0.00001808891,0.01809575],"study_design_scores_gemma":[0.02615261,0.003441799,0.9686946,0.0006228024,0.000372213,2.586779e-7,0.0001402626,0.0002998455,0.0001278878,0.00002727816,0.000002974268,0.0001174755],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930182,0.00006236674,0.00006731748,0.00005257196,0.00008624323,0.002292892,0.001273365,0.00002269641,0.003124411],"genre_scores_gemma":[0.9990681,0.00001965274,0.0001850947,0.00002390687,0.00005157669,0.000168083,0.0004262033,0.00001746177,0.00003993775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02574808,"threshold_uncertainty_score":0.9823833,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3169556370","doi":"10.1016/j.lungcan.2021.06.002","title":"The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer","year":2021,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; William Osler Health System; Humber Polytechnic; Dalhousie University; University of Toronto; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Lung cancer; Oncology; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01764954235470236,"gpt":0.3591299504094271,"spread":0.3414804080547247,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001844837,0.0005393939,0.001831986,0.000197487,0.0001507057,0.0000468591,0.0002650608,0.0002610407,0.0004564782],"category_scores_gemma":[0.00003883509,0.0003402971,0.0005292752,0.0007948669,0.0000651716,0.00008627549,0.00007860466,0.0005107764,0.000001663445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009262536,"about_ca_system_score_gemma":0.003140051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0010525,"about_ca_topic_score_gemma":0.001387393,"domain_scores_codex":[0.9976324,0.00008073192,0.000834118,0.0005936616,0.0003348652,0.0005241652],"domain_scores_gemma":[0.9980575,0.000312295,0.000590375,0.0006304755,0.0002925228,0.0001167941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008859175,0.0005827879,0.01038483,0.04722293,0.005195775,0.00007052036,0.003633783,0.0003385282,0.0001389696,0.00007026233,0.01131696,0.9209561],"study_design_scores_gemma":[0.004147048,0.00007821248,0.001099096,0.05483792,0.00677981,0.00001047403,0.0004876457,0.0008175225,0.00005624554,0.000001863896,0.9310977,0.0005864847],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003750189,0.9935294,0.00006989514,0.0002138226,0.001128412,0.002276009,0.0003049919,0.00003397343,0.002068483],"genre_scores_gemma":[0.0006392153,0.9907337,0.0005877428,0.0001179985,0.0003520566,0.002471549,0.0002055422,0.0001246886,0.004767551],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9203696,"threshold_uncertainty_score":0.9999049,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2022580888","doi":"10.1016/s0169-5002(03)00228-9","title":"The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data","year":2003,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Red Cross Society","funders":"","keywords":"Medicine; Radiation therapy; Hilum (anatomy); NODAL; Lung cancer; Cancer; Oncology; Internal medicine; Radiology","retraction":null,"screen_n_in":null,"score":{"opus":0.02899641451280294,"gpt":0.3789804832824597,"spread":0.3499840687696568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004318781,0.000246895,0.0006493432,0.0002157966,0.00009598065,0.00002291665,0.0002353297,0.0001023548,0.0002468924],"category_scores_gemma":[0.00001594405,0.000154336,0.0001708428,0.0007032671,0.0001355076,0.0001131234,0.00003902405,0.0001799664,1.585148e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008787527,"about_ca_system_score_gemma":0.0008567771,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01723391,"about_ca_topic_score_gemma":0.006953726,"domain_scores_codex":[0.998104,0.0001430442,0.000393163,0.0005448299,0.0004575152,0.0003575007],"domain_scores_gemma":[0.9983836,0.0001870451,0.0002798855,0.0008576558,0.0001327406,0.0001590107],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009057873,0.000799112,0.9843317,0.0001618099,0.00188554,0.00001064242,0.0004686316,0.003503042,0.0005735082,0.00007898444,0.004812146,0.002469047],"study_design_scores_gemma":[0.004918761,0.0008097285,0.9330577,0.0006600443,0.001413559,0.000003191629,0.000106378,0.05648636,0.0008362326,0.00000806831,0.00149304,0.0002068941],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9676621,0.03013502,0.00002406861,0.000683095,0.000141495,0.0007135497,0.000201002,0.0000104428,0.0004292293],"genre_scores_gemma":[0.9819512,0.01698858,0.0002114748,0.0000856394,0.0001231423,0.000164107,0.000141732,0.00003359206,0.0003004698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05298332,"threshold_uncertainty_score":0.9893104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2126270742","doi":"10.1016/j.lungcan.2009.11.018","title":"Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology","year":2009,"lang":"en","type":"review","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Erlotinib; Gefitinib; Oncology; Cetuximab; Bevacizumab; Internal medicine; Lung cancer; Adenocarcinoma; Clinical trial; Chemotherapy; Cancer; Epidermal growth factor receptor; Cisplatin; Colorectal cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04081135753217011,"gpt":0.4496065279671237,"spread":0.4087951704349536,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002354864,0.0003342013,0.001801007,0.0002136443,0.00003311336,0.000004073315,0.0002308698,0.0002804339,0.00006389949],"category_scores_gemma":[0.00008977702,0.0002251076,0.0003548017,0.0004406138,0.00004615069,0.00007543611,0.00003612487,0.0001477777,2.084006e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004538605,"about_ca_system_score_gemma":0.001430386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005839963,"about_ca_topic_score_gemma":0.005909061,"domain_scores_codex":[0.9974024,0.0001627806,0.001388417,0.0003968044,0.0004143017,0.0002352633],"domain_scores_gemma":[0.9964308,0.000198984,0.002393207,0.00044991,0.0004643491,0.00006280268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004041657,0.00139197,0.00364138,0.005659519,0.001305977,0.00000650206,0.004334113,0.000767379,0.00008415378,0.000004239354,0.0003381485,0.9820625],"study_design_scores_gemma":[0.007236693,0.001551867,0.00298668,0.05208242,0.006808992,0.000004630886,0.0004453757,0.000503578,0.00473946,0.000008087071,0.9232584,0.0003738455],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01063804,0.9820114,0.000002224985,0.00112139,0.0007997632,0.002223581,0.001023439,0.00001046428,0.002169717],"genre_scores_gemma":[0.006168726,0.9900777,0.0004916213,0.00003426832,0.0002400808,0.000519323,0.0003745883,0.00003797593,0.002055721],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9816886,"threshold_uncertainty_score":0.9992828,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2155240409","doi":"10.1016/j.lungcan.2005.07.003","title":"Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: A possible interaction with polymorphisms in the interleukin 1 beta gene","year":2005,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Norges Forskningsråd; Cancer Research Society; Kreftforeningen; Cancer Research Institute","keywords":"Lung cancer; Interleukin 1 receptor antagonist; Medicine; Odds ratio; Carcinogenesis; Allele; Immunology; Internal medicine; Receptor antagonist; Oncology; Cancer research; Cancer; Gene; Genetics; Receptor; Biology; Antagonist","retraction":null,"screen_n_in":null,"score":{"opus":0.004553480793773716,"gpt":0.2528051081569987,"spread":0.248251627363225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001847755,0.000233873,0.0002312108,0.00009628817,0.00009601146,0.00004159912,0.0002652163,0.0001237438,0.0001693165],"category_scores_gemma":[0.000009169258,0.0001734772,0.0000800475,0.0001712614,0.0001414517,0.00002582619,0.0000874367,0.0002193874,0.000001505424],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001026285,"about_ca_system_score_gemma":0.0001365159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002870064,"about_ca_topic_score_gemma":0.006411185,"domain_scores_codex":[0.9987502,0.000102398,0.0003275506,0.0003709073,0.0001451028,0.0003038075],"domain_scores_gemma":[0.9992867,0.00001437239,0.0002342223,0.0003585564,0.00006383777,0.00004232406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001168488,0.0001130232,0.1903771,0.00005719825,0.0004608613,0.000003939407,0.002311237,0.0002635947,0.7855401,0.00002197919,0.004702349,0.01498012],"study_design_scores_gemma":[0.002030187,0.0003230684,0.03156769,0.0001911053,0.000183434,0.00003396011,0.0004545641,0.0007853046,0.9393333,0.00000357825,0.02469076,0.0004030773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795723,0.0183371,0.0001272659,0.0009464608,0.0002387473,0.0003229711,0.0001214768,0.000008694677,0.0003249889],"genre_scores_gemma":[0.9923257,0.005649786,0.0002568346,0.0003991468,0.0003094047,0.0001617683,0.00009613156,0.0000345417,0.0007666373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1588094,"threshold_uncertainty_score":0.7074195,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2104963800","doi":"10.1016/s0169-5002(00)00116-1","title":"Co-expression of epidermal growth factor receptor and transforming growth factor-α is independent of ras mutations in lung adenocarcinoma","year":2000,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Autocrine signalling; Epidermal growth factor receptor; TGF alpha; Cancer research; Epidermal growth factor; Adenocarcinoma; Transforming growth factor; Signal transduction; Medicine; Biology; Receptor; Internal medicine; Cancer; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01366124753916978,"gpt":0.3215154356152042,"spread":0.3078541880760344,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004635032,0.0001865291,0.0004042448,0.0001780011,0.00006387787,0.000008439626,0.00006482637,0.0001152523,0.002616237],"category_scores_gemma":[0.00001566184,0.0001562098,0.00009172868,0.0002160128,0.00008204889,0.0002199755,0.000007704024,0.0001587282,0.000002291965],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002665028,"about_ca_system_score_gemma":0.0002461527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001993193,"about_ca_topic_score_gemma":0.0001063713,"domain_scores_codex":[0.9986851,0.00003756031,0.0004467973,0.0002874196,0.0003018447,0.0002412688],"domain_scores_gemma":[0.9994168,0.00007496043,0.0001228028,0.0001477975,0.0001101864,0.0001275078],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002815915,0.0002052873,0.9451855,0.000798522,0.0002235772,0.00001156491,0.01414004,0.00001649512,0.03301105,0.00006697656,0.0005581494,0.005501277],"study_design_scores_gemma":[0.004525041,0.0001657599,0.7503831,0.0008129383,0.0003437298,0.000009931118,0.0004414202,0.0001904109,0.2426283,0.00004699769,0.0002495611,0.0002028348],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927335,0.003836663,0.00009649895,0.0005437018,0.00009022484,0.0007471961,0.00052444,0.00002107713,0.00140669],"genre_scores_gemma":[0.9977569,0.001015116,0.000251698,0.000133428,0.00005805115,0.0001019521,0.00006533025,0.00002810557,0.0005894068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2096172,"threshold_uncertainty_score":0.9982955,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054847513","doi":"10.1016/j.lungcan.2005.04.008","title":"cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer","year":2005,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Fondation de France; Ligue Contre le Cancer","keywords":"Gemcitabine; Medicine; Oncology; Chemotherapy; Internal medicine; Lung cancer; Immunohistochemistry; Univariate analysis; Cancer research; Nucleoside analogue; Nucleoside; Multivariate analysis; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01194210589683289,"gpt":0.3245001958730316,"spread":0.3125580899761987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001588612,0.0003428497,0.0005356151,0.0002282488,0.0001596292,0.00002267689,0.0002608904,0.00003650158,0.0002957315],"category_scores_gemma":[0.0002153976,0.0003053865,0.0001154483,0.0003634453,0.00005077057,0.0003845516,0.0002044478,0.0004463597,0.000004077348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008000468,"about_ca_system_score_gemma":0.0003154083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002366068,"about_ca_topic_score_gemma":0.001429291,"domain_scores_codex":[0.997097,0.00005936062,0.0004961974,0.0007208793,0.00061946,0.00100715],"domain_scores_gemma":[0.9985979,0.0001565842,0.0001835145,0.0004474996,0.0002916263,0.0003229341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002159536,0.0006059681,0.9237588,0.001629871,0.00004783766,0.00006551352,0.0005593102,0.003899626,0.03824175,0.000003608764,0.01133082,0.01769733],"study_design_scores_gemma":[0.04783671,0.0017581,0.5794672,0.005980884,0.0002851326,0.00001128052,0.0002162637,0.02513683,0.2762978,0.0000249221,0.06163995,0.00134487],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894077,0.00355156,0.0001563557,0.00128556,0.0009350816,0.002861522,0.0001070551,0.0001018141,0.001593361],"genre_scores_gemma":[0.9862382,0.001257773,0.002358052,0.0003964313,0.0007867995,0.00182002,0.00005567355,0.0001171729,0.006969817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3442916,"threshold_uncertainty_score":0.9999398,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1977749101","doi":"10.1016/j.lungcan.2004.07.040","title":"Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer","year":2004,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Lung cancer; Stage (stratigraphy); Univariate analysis; Carboplatin; Multivariate analysis; Performance status; Chemotherapy; Population; Histology; Cancer; Gastroenterology; Oncology; Cisplatin","retraction":null,"screen_n_in":null,"score":{"opus":0.01568834593069632,"gpt":0.3198114188996633,"spread":0.304123072968967,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008421759,0.0002503021,0.0003889753,0.0000583028,0.0001609013,0.00001707598,0.0001129216,0.0000916123,0.0002420641],"category_scores_gemma":[0.00001609445,0.0001422029,0.0001362274,0.0002762539,0.00005173022,0.00008931672,0.00001381777,0.0001612312,2.959547e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007220696,"about_ca_system_score_gemma":0.0009308152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000650982,"about_ca_topic_score_gemma":0.0039502,"domain_scores_codex":[0.9988668,0.0000160181,0.0002410141,0.0003065775,0.0002027018,0.0003668825],"domain_scores_gemma":[0.9989508,0.0001278056,0.0002622583,0.0002633428,0.0002950068,0.000100719],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002432196,0.002393842,0.7832205,0.002153345,0.01137901,0.00001867418,0.04872122,0.01885689,0.09145847,0.0001129557,0.01082261,0.02843034],"study_design_scores_gemma":[0.05589565,0.002772803,0.6095937,0.004151645,0.00516372,0.000002256843,0.002773231,0.001423111,0.3076573,0.0001307086,0.009280374,0.001155543],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845021,0.009451302,0.0009087255,0.001543088,0.0003404039,0.00203327,0.0003265141,0.00004947116,0.0008451316],"genre_scores_gemma":[0.9946329,0.0005345236,0.0002599327,0.0006874033,0.0001711794,0.0009532807,0.00008843612,0.00006844427,0.002603904],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2161988,"threshold_uncertainty_score":0.5798864,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111088515","doi":"10.1016/j.lungcan.2004.02.009","title":"15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer","year":2004,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Lung cancer; Surgical resection; Single Center; Vena cava; Superior vena cava; Resection; Center (category theory); Surgery; Radiology; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.01292059429815852,"gpt":0.2944366569894449,"spread":0.2815160626912864,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004685197,0.000164276,0.0002723793,0.0000374045,0.00008102702,0.00001671104,0.0001029118,0.00007342921,0.0001366245],"category_scores_gemma":[0.00000498974,0.0001041608,0.000133996,0.0001908395,0.00009152988,0.00006087973,0.00003214664,0.000110683,9.477799e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001106112,"about_ca_system_score_gemma":0.000369958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002988818,"about_ca_topic_score_gemma":0.002713747,"domain_scores_codex":[0.9988962,0.00001395969,0.0002001947,0.0003283684,0.0002585409,0.0003027117],"domain_scores_gemma":[0.9993421,0.00002975289,0.00009715196,0.0003159299,0.0001190358,0.00009607083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001433555,0.0008423501,0.9795581,0.0009173787,0.0003111897,0.00005454749,0.006222554,0.001091335,0.005692541,0.00004264801,0.002755605,0.001078172],"study_design_scores_gemma":[0.04354011,0.003229094,0.3475872,0.009021521,0.002062584,0.0001289859,0.00113069,0.0007640971,0.5390475,0.00001971339,0.0525094,0.0009590472],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992926,0.003418582,0.00004339296,0.001038336,0.0006563107,0.001176527,0.00007330764,0.00002056336,0.0006470071],"genre_scores_gemma":[0.9967538,0.0004833096,0.0001712875,0.0002380672,0.0003334298,0.001126529,0.00000825061,0.0000385263,0.0008468771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6319709,"threshold_uncertainty_score":0.4518218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}